Valuation : Certara, Inc.

Market Cap 1.21B 1.04B 981M 896M 1.68B 114B 1.68B 11.59B 4.5B 58.67B 4.55B 4.45B 189B P/E 2026 *
-38.5x
P/E 2027 * 847x
Enterprise Value 1.27B 1.09B 1.03B 937M 1.75B 120B 1.76B 12.12B 4.7B 61.37B 4.76B 4.65B 198B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3.05x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day-2.34%
1 week-4.91%
Current month-4.22%
1 month-2.34%
3 months+47.86%
6 months+12.46%
Current year-9.88%
1 week 7.9
Extreme 7.905
8.43
1 month 7.86
Extreme 7.855
8.88
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Free

Chief Financial Officer

63,532 0.0416%
7/15/26 A Other

Chief Financial Officer

191,850 0.1233%
6/1/26 A Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
-2.34%-4.91%-24.52%-47.66% 1.21B
-2.04%-2.69%+0.95%+50.11% 3,711B
-4.49%-6.42%+13.86%+1,039.41% 419B
-3.99%-14.01%-16.61%+18.65% 80.61B
-0.85%-10.15%+56.47%+118.03% 76.46B
-5.40%-11.02%-34.16%-15.43% 75.47B
-0.89%-6.09%-41.50%+185.80% 68.65B
-2.62%-0.44%+9.95%-8.15% 47.99B
+0.26%-8.79%-10.43%+52.29% 40.14B
-3.12%-2.02%+114.39%+252.57% 35.78B
Average -2.55%-6.65%+6.84%+164.56% 455.58B
Weighted average by Cap. -2.31%-3.57%+2.42%+143.60%

Financials

2026 *2027 *
Net sales 380M 327M 308M 281M 526M 35.89B 527M 3.64B 1.41B 18.41B 1.43B 1.4B 59.32B 390M 335M 315M 288M 539M 36.78B 540M 3.73B 1.45B 18.87B 1.46B 1.43B 60.79B
Net income -28.37M -24.41M -22.97M -20.98M -39.25M -2.68B -39.36M -271M -105M -1.37B -107M -104M -4.43B 1.74M 1.5M 1.41M 1.29M 2.4M 164M 2.41M 16.62M 6.45M 84.17M 6.52M 6.38M 271M
Net Debt 55.8M 48.02M 45.18M 41.27M 77.21M 5.27B 77.42M 534M 207M 2.7B 210M 205M 8.71B -23.11M -19.89M -18.71M -17.09M -31.98M -2.18B -32.07M -221M -85.81M -1.12B -86.79M -84.9M -3.61B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
04/09/26 $7.940 -2.34% 1,272,274
03/09/26 $8.130 -1.81% 2,125,056
02/09/26 $8.280 +2.22% 1,525,517
01/09/26 $8.100 -2.29% 2,480,188
31/08/26 $8.290 -0.72% 1,712,467
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
7.940USD
Average target price
8.335USD
Spread / Average Target
+4.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!